(Q46411211)

English

Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft

scientific article published on 4 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

author name string

J Hasskarl

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

A Zerweck

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

R Wäsch

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

G Ihorst

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

H Bertz

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

J Finke

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

language of work or name

0 references

publication date

4 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

47

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

277-282

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

Management of relapse after allo-SCT for AML and the role of second transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Donor lymphocyte infusions: the long and winding road: how should it be traveled?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell tra

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Graft-versus-leukemia reactions in allogeneic chimeras

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

21 January 2018

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell therapy of leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful allogeneic stem-cell transplantation with prophylactic stepwise G-CSF primed-DLIs for relapse after autologous transplantation in mantle cell lymphoma: a case report and literature review on the evidence of GVL effects in MCL.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed lymphocyte infusion in children given SCT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.45

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2011.45

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21460873

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46411211&oldid=2207850111"